title: [Other non-motor disorders in Parkinson's disease].
abstract: BACKGROUND
  In addition to the classic triad (tremor, rigidity and akinesia), Parkinson's disease (PD) is also accompanied by several non-motor disorders.
  
  
  OBJECTIVE
  To carry out an updated review of these non-motor symptoms in terms of their pathophysiology, epidemiology, clinical features and treatment.
  
  
  METHODS
  Autonomic disorders such as seborrhoeic dermatitis and disorders involving sweating, fatigue, weight loss or respiratory problems (dyspnea, inspiratory stridor) are highly prevalent and very disabling symptoms. In addition, they may be the main problem in a particular phase of PD (fatigue, stridor) and condition the quality of life of patients with Parkinson. They are often neglected and remain undetected. Although they may respond to dopaminergic agents, they usually require a different therapeutic approach. Studies are needed to evaluate new therapeutic perspectives that act against the pathophysiological mechanisms of these disorders.
  
  
  CONCLUSIONS
  PD affects systems other than the dopaminergic nigrostriatal. A better understanding of this pathology will make it possible to approach and optimise the treatment of the conditioning symptoms, thereby enhancing the welfare of patients with PD.
authors.affiliation: Hospital Clínico Universitario de Valladolid, España. med028563@saludalia.com
authors.forename: J
authors.initials: J
authors.lastname: Marco-Llorente
authors.forename: E
authors.initials: E
authors.lastname: Rojo-Martínez
mesh_terms: D001342:Autonomic Nervous System Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology*; D012628:Dermatitis, Seborrheic / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D015259:Dopamine Agents / Q000627:therapeutic use; D005221:Fatigue / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D006945:Hyperhidrosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D012135:Respiratory Sounds / Q000209:etiology / Q000503:physiopathology; D015431:Weight Loss
chemical_list: D015259:Dopamine Agents